Answers are grounded in this paper and cite their sources.
BACKGROUND: mutations cause developmental delay, short stature, and skeletal abnormalities in a syndrome called Albright's hereditary osteodystrophy. Because of imprinting, mutations on the maternal allele also cause obesity and hormone resistance (pseudohypoparathyroidism). METHODS: mutations on melanocortin 4 receptor (MC4R) signaling explains the obesity and whether the variable clinical spectrum in patients might be explained by the results of molecular assays. RESULTS: mutations (3.9±2.6 mIU per liter; P = 0.004). CONCLUSIONS: mutations that are identified by means of unbiased genetic testing differentially affect GPCR signaling pathways that contribute to clinical heterogeneity. Monogenic diseases are clinically more variable than their classic descriptions suggest. (Funded by Wellcome and others.).
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: